BtHCROSS - Dermal filler (cross-linked HA 1,5%/1,75%/2%)

BtHCROSS - Dermal filler (cross-linked HA 1,5%/1,75%/2%)
Product Description

BtHCROSS is a biocompatible cross-linked hyaluronic acid hydrogel intended as a dermatological treatment for aesthetic purposes. It is administered by intradermal injection and designed to restore and correct facial volumes and fill wrinkles and folds.
Depending on the depth of the wrinkles and the area to treat, there are 3 different models:

BtHCROSS 1.5%
- Correction of superficial wrinkles such as perioral lines.
- Lip enhancement and profiling.

BtHCROSS 1.75%
- Medium to deep skin depressions such as nasolabial folds

BtHCROSS 2%
- Facial contour remodelling and restoration of volumes.

Composition
BtHCROSS contains cross-linked hyaluronic acid of injectable grade obtained by biofermentation, dissolved in a physiological buffer with pharmacopeia quality ingredients and water for injection.



Read more Show less

i+Med S. Coop.

  • ES
  • 2018
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Contract Service
Distributor/Import Export
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Medical Devices
OTC
Out-licensing specialist
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    9004-61-9
  • Selling Points
    Reputation; GENERAL INFORMATION

    + European product: All the ingredients we use are 100% European origin, and the products are entirely manufactured at our facilities in the north of Spain.

    + MDR certificate: The submission, clinical trials and documentation required to obtain the MDR certificate have been submitted and we expect to receive it in 2024.

    + Wide range: We offer viscoelastic of different strengths so doctors can choose what best adjusts to their needs and mode of work.

    + Hyaluronic Acid specialization: We have been working with this complex polymer for 10 years. We not only add HA to our products, but we master it to explode its potential and obtain high-added value injectables.

    + Formulations: We carefully selected our HA’s molecular weight and polymer chain length to make it optimal for its purpose.

    + Non-animal HA

    + Available for distribution worldwide

  • Supplied from
    Spain
More specifications Fewer specifications
Sales Markets
Show more Show less

i+Med S. Coop.

  • ES
  • 2018
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Contract Service
Distributor/Import Export
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Medical Devices
OTC
Out-licensing specialist
Pharmaceutical Company (innovator finished products)
View company profile

More Products from i+Med S. Coop. (4)

  • ADAPTEK® TECHNOLOGY

    Product ADAPTEK® TECHNOLOGY

    ADAPTEK® TECHNOLOGY is the general name for our 4 international patents and expertise in nanotechnology and controlled release systems.This is a transversal technology that allows to develop customized biopolymeric nanohydrogels, allowing the load with different API (drugs, vitamins, growth factors, etc.)....
  • OpHLINE - Ophthalmic Viscosurgical Devices (HA 1,4%/2%/3%)

    Product OpHLINE - Ophthalmic Viscosurgical Devices (HA 1,4%/2%/3%)

    OpHLINE is an ophthalmic viscosurgical devise (OVD) indicated as a coadjuvant during surgical procedures, involving the anterior chamber of the eye, especially in cataract surgery, including the extraction of the lens and the insertion of intraocular lenses.
    OpHLINE is available in 3 models ...
  • TrHCROSS - Joint injections (cross-linked HA 2%)

    Product TrHCROSS - Joint injections (cross-linked HA 2%)

    TrHCROSS 2% is a biocompatible hydrogel of cross-linked sodium hyaluronate obtained by biofermentation. This is a single injection, designed to relieve joint pain in osteoarthritis by replacing natural joint fluid and replenishing lubricating and shock-absorbing functions.

    Properties
    ...
  • DayDrop - eye drops with the sustained-release system of ectoine

    Product DayDrop - eye drops with the sustained-release system of ectoine

    DayDrop is an ophthalmic solution with sustained release of ectoine, indicated to alleviate the ocular dryness and irritation produced by environmental factors (wind, dust, air conditioning, dry heat), prolonged use of screens or contact lenses and some pathologies that present the above mentioned symp...

i+Med S. Coop. resources (1)

  • i+Med Company profile

    Brochure i+Med Company profile

    i+Med is a biotech company formed by highly qualified personnel, focused on the R&D and manufacture of new products for third parties. Our ADAPTEK® TECHNOLOGY enables the development of customized biopolymeric nanohydrogels, allowing the load with different API (drugs, vitamins, growth factors, etc.). These intelligent nanoparticles could be programmed to respond to external stimulus (E.g. pH or t˚) that allow the controlled release of APIs. As a result, we can develop high added value and differentiated products that provide our customers with a key competitive advantage in t...